AI assistant
BioCardia, Inc. — Director's Dealing 2009
Oct 29, 2009
35081_dirs_2009-10-29_e3d1e7ae-426c-4e5f-963e-4ebfa61b13d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardo Medical, Inc. (CDOM.OB)
CIK: 0000925741
Period of Report: 2009-06-30
Reporting Person: FROST PHILLIP MD ET AL (10% Owner)
Reporting Person: Frost Gamma Investments Trust (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-06-30 | Common Stock, par value $0.001 per share | P | 857143 | $0.35 | Acquired | 31822339 | Indirect |
| 2009-10-27 | Common Stock, par value $0.001 per share | P | 1428572 | $0.35 | Acquired | 33250911 | Indirect |
Footnotes
F1: These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder.
Remarks:
Exhibit List: Exhibit 99 - Joint Filer Information